Advertisement

Topics

Companies Related to "Euronext" [Most Relevant Company Matches] RSS

05:32 EDT 18th October 2017 | BioPortfolio

Here are the most relevant search results for "Euronext" found in our extensive corporate database of over 50,000 company records.

Showing "Euronext" Companies 1–25 of 55

Relevant

Euronext N.V

Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The Euronext group expanded at the beginning of 2002 with the acquisition of LIFFE (London International Financial Futures and Options Exchange) and the merger with the Portuguese exchange BVLP (Bolsa de ...


NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities ...

Nutreco Holding N.V.

Nutreco Holding N.V. is an international company in the animal nutrition and fish feed markets, where it seeks to create added value through its knowledge of the food chains. The company has a selected presence in various stages of the food production chains. Nutreco’s strategy aims to regain solid profit growth, reduce earnings volatility and improve return on invested capital. In order to achi...


Probably Relevant

Gemalto

Gemalto (Euronext NL 0000400653 GTO) is the world leader in digital security with 2009 annual revenues of €1.65 billion, and over 10,000 employees operating out of 75 offices, with research and service centers in 41 countries.

Galapagos nv

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs with service activities. The joint venture operated until 2002 when the Company raised €23.4 million in a private placement. In May 2005, the Company raised €22.4 million through its initial publ...

Sanofi Pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

sanofi-pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

UCB

UCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing more than 9,000 people in over 40 countries, UCB produced revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

Sanofi SA

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

Merck and sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Ascenta Therapeutics

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, please visit: www.sanofi-aventis.com.

Sanofi Aventis Groupe

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Transgene S.A.

Transgene (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cell...

IBA

IBA develops and markets leading-edge technologies, pharmaceuticals and tailor-made solutions for healthcare with a focus on cancer diagnosis and therapy. Leveraging on its scientific expertise, IBA is also active in the field of industrial sterilization and ionization. Listed on the pan-European stock exchange EURONEXT, IBA is included in the BelMid Index...

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, www.sanofi-aventis.us or www.sanofi-aventis.com.

UCB, Inc.

UCB, Brussels, Belgium (www.ucb-usa.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,500 people in about 40 countries, the company generated revenue of ...

Sanofi and Warp Drive Bio

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE:SNY) . For more information, www.sanofi-aventis.us or www.sanofi-aventis.com.

GROUPE IDI

Le Groupe IDI, pionnier du capital investissement, est l'un des principaux intervenants indépendants du métier.Créé en 1970 par les Pouvoirs Publics pour apporter des fonds propres aux PME , l’IDI a été repris par son management en 1987.Les actions de l’IDI ont été introduites en Bourse (second marché de Paris) en juin 1991. Ses animateurs détiennent 93% du capital. La société est ...

SANOFI

SANOFI concentrate their research efforts where the most pressing medical needs and public health issues are, bringing solutions to patients and contributing to a healthier society worldwide: DIABETES CANCER CARDIOVASCULAR DISEASES INFECTIOUS DISEASES ELEDERLY PATIENTS & AGING OPHTHALMOLOGY RARE DISEASES & MULTIPLE SCLEROSIS R&D PORTFOLIO At the ...

Quest for Growth NV

Quest for Growth focuses on European technology-based growth companies in sectors such as life sciences, information technology, software, semiconductors, telecom, electronics, new materials and special situations in other growth sectors. Funds under management amount to € 105 million, on June 30th, 2006.Quest for Growth has been listed on Euronext Brussels since September 23rd, 1998.

Sopheon

Sopheon (LSE:SPE) is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon’s solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on ...

GFI Informatique

GFI Informatique est une Société Anonyme de droit français à Conseil d'Administration, régie par la loi du 24 juillet 1966, au capital de 92 679 204 euros.Le titre est coté au premier marché d'Euronext et fait partie du compartiment B de l'Eurolist (code ISIN : FR 0004038099).Le Conseil d'administration, présidé par Jacques Tordjman, Président-Directeur Général du Groupe GFI Informatiq...

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabetes, AIDS and Alzheimer’s. BioPharma Fund invests in these innovator companies.The Fund is a sub-fund of TONIC Sector Fund SICAV, a Luxembourg-based investment company.BioPharma Fund’s Common Share...

BioAlliance Pharma

BioAlliance Pharma (Euronext Paris: BIO) is an emerging specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in cancer, HIV, and severe and opportunistic infections.To attack the challenge of resistance, the company has multiple product opportunities in two broad proprietary drug delivery systems represented by the Lauriad® adhesive tech...


More From BioPortfolio on "Euronext"

Quick Search
Advertisement
 

Corporate Database Quicklinks